{"id":"W2143715586","doi":"10.1016/j.ctrv.2015.07.003","title":"Obinutuzumab in hematologic malignancies: Lessons learned to date","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Obinutuzumab; Hematologic Neoplasms; Oncology; Intensive care medicine; Internal medicine; Cancer; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008420106,0.001028802,0.007252051,0.0004598905,0.00005300785,0.00004663126,0.0004809168,0.0004441658,0.0005613858],"category_scores_gemma":[0.0002602616,0.0006121657,0.0009717857,0.001372044,0.0000954481,0.00006215469,0.0002212597,0.0004140158,0.003580005],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1277653,"about_ca_system_score_gemma":0.0413474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001622718,"about_ca_topic_score_gemma":0.0003499169,"domain_scores_codex":[0.9951132,0.0005113779,0.001533707,0.001320364,0.0005195815,0.00100178],"domain_scores_gemma":[0.9967492,0.0001546475,0.0004498661,0.001841691,0.0001108942,0.0006937039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003654416,0.0001372661,0.000002534238,0.02976282,0.0002117842,0.0009501651,0.0001701856,0.000001986905,4.460452e-7,0.00005207542,0.01344659,0.9552276],"study_design_scores_gemma":[0.004478018,0.0004188678,3.085538e-7,0.06569,0.001540134,0.0004945007,0.00001935967,0.000009714558,0.00000387913,0.00001315434,0.9268864,0.0004455918],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002213228,0.9868294,0.000003472553,0.0004094963,0.0002517578,0.008805663,0.0001013713,0.0000715448,0.003505187],"genre_scores_gemma":[0.000002573266,0.9769496,0.0003583516,0.0002125529,0.000265253,0.01067874,0.0003477357,0.0001242868,0.01106088],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.954782,"threshold_uncertainty_score":0.999633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4738322693286079,"score_gpt":0.5435361784067422,"score_spread":0.06970390907813429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}